Three Dimensional Bioprinting for Hepatic Tissue Engineering: From In Vitro Models to Clinical Applications

Author:

Kasturi Meghana,Mathur Vidhi,Gadre Mrunmayi,Srinivasan Varadharajan,Vasanthan Kirthanashri S.ORCID

Abstract

AbstractFabrication of functional organs is the holy grail of tissue engineering and the possibilities of repairing a partial or complete liver to treat chronic liver disorders are discussed in this review. Liver is the largest gland in the human body and plays a responsible role in majority of metabolic function and processes. Chronic liver disease is one of the leading causes of death globally and the current treatment strategy of organ transplantation holds its own demerits. Hence there is a need to develop an in vitro liver model that mimics the native microenvironment. The developed model should be a reliable to understand the pathogenesis, screen drugs and assist to repair and replace the damaged liver. The three-dimensional bioprinting is a promising technology that recreates in vivo alike in vitro model for transplantation, which is the goal of tissue engineers. The technology has great potential due to its precise control and its ability to homogeneously distribute cells on all layers in a complex structure. This review gives an overview of liver tissue engineering with a special focus on 3D bioprinting and bioinks for liver disease modelling and drug screening.

Funder

Indian Council of Medical Research

Manipal Academy of Higher Education, Manipal

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Medicine (miscellaneous)

Reference293 articles.

1. Palakkan AA, Hay DC, Anil Kumar PR, Kumary TV, Ross JA. Liver tissue engineering and cell sources: issues and challenges. Liver Int. 2013;33:666–76.

2. Sharma A, Nagalli S. Chronic liver disease. InStatPearls 2021. StatPearls Publishing.

3. Liver Disease in India. World Life Expectancy. Available from: https://www.worldlifeexpectancy.com/india-liver-disease

4. World Health Statistics 2022. Available from: https://www.who.int/news/item/20-05-2022-world-health-statistics-2022

5. Cheemerla S, Balakrishnan M. Global epidemiology of chronic liver disease. Clin Liver Disease. 2021;17:365.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3